Literature DB >> 2788140

Characterization of protective T cells in the acquired response to Leishmania donovani in genetically determined cure (H-2b) and noncure (H-2d) mouse strains.

O M Ulczak1, E Ghadirian, E Skamene, J M Blackwell, P A Kongshavn.   

Abstract

The response to reinfection with Ethiopian Leishmania donovani was evaluated in genetically determined noncure (H-2d) B10.D2 mice that are able to resolve infection due to sublethal irradiation pretreatment after inoculation with a low parasite dose and in C57BL/10 mice that demonstrate the genetically determined cure (H-2b) response to L. donovani. It was found that after resolution of primary infection, C57BL/10 (cure) mice and sublethally irradiated B10.D2 (noncure) mice were resistant to rechallenge with L. donovani. Noncure mice inoculated with a low dose of amastigotes were not, however, solidly immune to reinfection. Adoptive-cell transfer experiments were then done to determine the T-cell subset that was associated with resistance to reinfection, and thus the development of immunity, in sublethally irradiated B10.D2 noncure mice and in C57BL/10 cure mice. T-cell-enriched preparations from spleens of immune donors were treated with subset-specific antibodies and complement prior to adoptive transfer in unprimed recipients. The results of the adoptive transfer experiments provide evidence that the genetically determined cure (H-2b) response in C57BL/10 mice and the cure response in genetically determined noncure (H-2d) B10.D2 mice brought about by sublethal irradiation pretreatment are mediated primarily by an L3T4+ Lyt-2- T cell.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788140      PMCID: PMC313543          DOI: 10.1128/iai.57.9.2892-2899.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar.

Authors:  S Pampiglione; P E Manson-Bahr; M La Placa; M A Borgatti; S Musumeci
Journal:  Trans R Soc Trop Med Hyg       Date:  1975       Impact factor: 2.184

2.  Studies on Mediterranean leishmaniasis. 2. Asymptomatic cases of visceral leishmaniasis.

Authors:  S Pampiglione; P E Manson-Bahr; F Giungi; G Giunti; A Parenti; G Canestri Trotti
Journal:  Trans R Soc Trop Med Hyg       Date:  1974       Impact factor: 2.184

3.  Spectral model of leishmaniasis in congenic strains of mice.

Authors:  L H Semprevivo; L J DeTolla; H C Passmore; N C Palczuk
Journal:  J Parasitol       Date:  1981-02       Impact factor: 1.276

4.  Characterization of in vitro proliferative responses of human lymphocytes to leishmanial antigens.

Authors:  D J Wyler; F I Weinbaum; H R Herrod
Journal:  J Infect Dis       Date:  1979-08       Impact factor: 5.226

5.  Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.

Authors:  J J Stern; M J Oca; B Y Rubin; S L Anderson; H W Murray
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

6.  Influence of H-2 complex on acquired resistance to Leishmania donovani infection in mice.

Authors:  J Blackwell; J Freeman; D Bradley
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

7.  Immunological responses of L. donovani infection in mice and significance of T cell in resistance to experimental leishmaniasis.

Authors:  H R Rezai; J Farrell; E L Soulsby
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

8.  Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice.

Authors:  D J Bradley; J Kirkley
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

9.  Cellular immunity to Leishmania donovani. II. Evidence for synergy between thymocytes and lymph node cells in reconstitution of acquired resistance to L. donovani in mice.

Authors:  C B Skov; D W Twohy
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

10.  Deficiency of the fifth component of complement in mice with an inherited complement defect.

Authors:  U R Nilsson; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1967-01-01       Impact factor: 14.307

View more
  4 in total

1.  Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.

Authors:  Shraddha Kumari; Mukesh Samant; Prashant Khare; Pragya Misra; Sujoy Dutta; Bala Krishna Kolli; Sharad Sharma; Kwang Poo Chang; Anuradha Dube
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

2.  Genetic predisposition to self-curing infection with the protozoan Leishmania chagasi: a genomewide scan.

Authors:  Selma M B Jeronimo; Priya Duggal; Nicholas A Ettinger; Eliana T Nascimento; Gloria R Monteiro; Angela P Cabral; Nubia N Pontes; Henio G Lacerda; Paula V Queiroz; Carlos E M Gomes; Richard D Pearson; Jenefer M Blackwell; Terri H Beaty; Mary E Wilson
Journal:  J Infect Dis       Date:  2007-09-13       Impact factor: 5.226

3.  Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis.

Authors:  Saeed Ahmed; M Colmenares; L Soong; K Goldsmith-Pestana; L Munstermann; R Molina; Diane McMahon-Pratt
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

4.  A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice.

Authors:  M E Wilson; B M Young; K P Andersen; J V Weinstock; A Metwali; K M Ali; J E Donelson
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.